Ropinirole in a Child With Attention-Deficit Hyperactivity Disorder and Restless Legs Syndrome

Konofal, Eric; Arnulf, Isabelle; Lecendreux, Michel; Mouren, Marie-Christine

doi:10.1016/j.pediatrneurol.2004.11.007

« Previous Next »Pediatric Neurology
Volume 32, Issue 5 , Pages 350-351, May 2005

Ropinirole in a Child With Attention-Deficit Hyperactivity Disorder and Restless Legs Syndrome

Eric Konofal, MD, PhD
- Service de Psychopathologie de l’Enfant et de l’Adolescent, Hôpital Robert Debré, Paris, France.
- Fédération des Pathologies du Sommeil, Hôpital Pitié Salpêtrière, Paris, France.
- Communications should be addressed to: Dr. Konofal; Service de Psychopathologie de l’Enfant et de l’Adolescent; Hôpital Robert Debré 48, bd Serrurier; 75020 Paris, France.
Isabelle Arnulf, MD, PhD
- Fédération des Pathologies du Sommeil, Hôpital Pitié Salpêtrière, Paris, France.
Michel Lecendreux, MD
- Service de Psychopathologie de l’Enfant et de l’Adolescent, Hôpital Robert Debré, Paris, France.
Marie-Christine Mouren, MD
- Service de Psychopathologie de l’Enfant et de l’Adolescent, Hôpital Robert Debré, Paris, France.

Received 28 July 2004; accepted 23 November 2004. published online 07 March 2005.

A 6-year-old male being treated with limited efficacy by methylphenidate immediate release for attention-deficit hyperactivity disorder also presented with sleep disruption due to potential restless legs/periodic limb movement syndrome. Treatment with the dopamine agonist ropinirole resulted in a significant improvement in both his attention-deficit hyperactivity disorder symptoms and sleep problems.